Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer's disease and a therapeutic device to stop that disorder in its earliest stages.
<p><a href="https://www.learningwithlowell.com/a-cure-for-alzheimers-disease-ceo-of-leucadia-therapeutics-doug-ethell-learning-with-lowell-176/" rel="nofollow">Source</a></p>

Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer's disease and a therapeutic device to stop that disorder in its earliest stages. Source

Doug Ethell is the founder and CEO of Leucadia Therapeutics, a pre-clinical stage company developing an early diagnostic for Alzheimer's disease and a therapeutic device to stop that disorder in its earliest stages.
<p><a href="https://www.learningwithlowell.com/a-cure-for-alzheimers-disease-ceo-of-leucadia-therapeutics-doug-ethell-learning-with-lowell-176/" rel="noopener noreferrer">Source</a></p>

Share A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176

Sign up to save your podcasts

A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176

A Cure for Alzheimer’s disease? – CEO of Leucadia Therapeutics Doug Ethell -Learning with Lowell 176